Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
Become a Member | Sign in


May 2014 Onwards
Scientific News
Lucentis Effective for Proliferative Diabetic Retinopathy
NIH-funded clinical trial marks first major advance in therapy in 40 years.
Blocking the Transmission Of Malaria Parasites
Vaccine candidate administered for the first time in humans in a phase I clinical trial led by Oxford University’s Jenner Institute, with partners Imaxio and GSK.
First Therapy Appearing to Reverse Decline in Parkinson’s
An FDA-approved drug for leukemia improved cognition, motor skills and non-motor function in patients with Parkinson’s disease and Lewy body dementia in a small clinical trial, say researchers at Georgetown University Medical Center (GUMC).
Gene Therapy Staves Off Blindness from Retinitis Pigmentosa in Canine Model
NIH-funded study suggests therapeutic window may extend to later-stage disease.
Treatment for Rare Bleeding Disorder is Effective
Researchers in Manchester have demonstrated for the first time the relative safety and effectiveness of treatment, eltrombopag, in children with persistent or chronic immune thrombocytopenia (ITP), as part of an international duo of studies.
HIV Vaccine Human Trials Begin
Baltimore-based Institute has begun enrolling volunteers for initial phase 1 clinical trials.
New Therapy Reduces Symptoms of Inherited Enzyme Deficiency
A phase three clinical trial of a new enzyme replacement medication, sebelipase alfa, showed a reduction in multiple disease-related symptoms in children and adults with lysosomal acid lipase deficiency, an inherited enzyme deficiency that can result in scarring of the liver and high cholesterol.
Fixing Holes in the Heart Without Invasive Surgery
UV-light enabled catheter is a medical device which represents a major shift in how cardiac defects are repaired.
Atriva Therapeutics GmbH Develops Innovative Flu Drug
Highly effective against seasonal and pandemic influenza.
Study Removes Cancer Doubt for Multiple Sclerosis Drug
Researchers from Queen Mary University of London are calling on the medical community to reconsider developing a known drug to treat people with relapsing Multiple sclerosis after new evidence shows it does not increase the risk of cancer as previously thought.
CMC Strategy Forum Europe 2014
05 May 2014 - 07 May 2014
Sorrento, Italy
CMC Strategy Forum Europe 2014
06 May 2014 - 12 Jun 2014
LC/MS Fundamentals and Applications
06 May 2014 - 12 Jun 2014
Mass Spectral Interpretation
19 May 2014 - 20 May 2014
Copenhagen, Denmark
Method Development and Optimization for LC/MS/MS
19 May 2014 - 21 May 2014
Paris, France
PharmAccess Leaders Forum
GCP and Quality in Clinical Trials
20 May 2014 - 21 May 2014
Cologne, Germany
GCP and Quality in Clinical Trials
20 May 2014 - 23 May 2014
Shanghai, China
4th Annual Biomanufacturing 2014
21 May 2014 - 22 May 2014
Copenhagen, Denmark
Mass Spectral Interpretation
TagLite® 2 cell assay - the next dimension to discovering new antibody drugs
21 May 2014 - 21 May 2014
Online, webinar
TagLite® 2 cell assay - the next dimension to discovering new antibody drugs
<< 1 2 3 4 5 6 7 >>

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos